Interleukin (IL)-2 is the predominant cytokine that is produced by naive Th cells in a primary response. It is required for proliferation and differentiation of Th precursor cells into effector cells. Initial high-level IL-2 production is followed by its decline, and the concomitant induction of cytokines that are typical of the differentiated state. Although the factors that are responsible for the early induction of IL-2 are well defined, the mechanisms that are responsible for its down-regulation in later stages of Th development have not been studied as much. Previous work from our laboratory revealed a repressor function for the T-box transcription factor, T-bet, in IL-2 gene transcription. Here, we report that T-betS508 is required for the optimal repression of IL-2 production in developing Th1 cells. Phosphorylation of T-betS508 by casein kinase I and glycogen synthase kinase-3 kinases accompanies T-bet's interaction with the RelA nuclear factor–κB transcription factor. Heterodimerization of T-bet and RelA interferes with the binding of RelA to the IL-2 promoter, and hence, transcriptional activation of the IL-2 gene by RelA.
Skip Nav Destination
Article navigation
7 November 2005
Article Contents
Article|
November 07 2005
IL-2 production in developing Th1 cells is regulated by heterodimerization of RelA and T-bet and requires T-bet serine residue 508
Eun Sook Hwang,
Eun Sook Hwang
1Division of Molecular Life Sciences and College of Pharmacy, Ewha Womans University, Seoul, Korea 121-742
2Department of Immunology and Infectious Diseases, Harvard School of Public Health
Search for other works by this author on:
Jeong-Ho Hong,
Jeong-Ho Hong
4Center for Cancer Research, Department of Biology, Massachusetts Institute of Technology, Cambridge, MA 02139
Search for other works by this author on:
Laurie H. Glimcher
Laurie H. Glimcher
2Department of Immunology and Infectious Diseases, Harvard School of Public Health
3Department of Medicine, Harvard Medical School, Boston, MA 02115
Search for other works by this author on:
Eun Sook Hwang
1Division of Molecular Life Sciences and College of Pharmacy, Ewha Womans University, Seoul, Korea 121-742
2Department of Immunology and Infectious Diseases, Harvard School of Public Health
Jeong-Ho Hong
4Center for Cancer Research, Department of Biology, Massachusetts Institute of Technology, Cambridge, MA 02139
Laurie H. Glimcher
2Department of Immunology and Infectious Diseases, Harvard School of Public Health
3Department of Medicine, Harvard Medical School, Boston, MA 02115
CORRESPONDENCE Laurie H. Glimcher: [email protected] OR Eun Sook Hwang: [email protected]
Abbreviations used: ChIP, chromatin immunoprecipitation; CKI, casein kinase 1; CREB, cyclic AMP response element binding protein; CREM, cyclic AMP resonsive element modulator gene; GSK, glycogen synthase kinase; MS, mass spectrometry; PKA, protein kinase A; S508, serine 508; Thp, Th precursor.
Received:
May 23 2005
Accepted:
September 27 2005
Online ISSN: 1540-9538
Print ISSN: 0022-1007
The Rockefeller University Press
2005
J Exp Med (2005) 202 (9): 1289–1300.
Article history
Received:
May 23 2005
Accepted:
September 27 2005
Citation
Eun Sook Hwang, Jeong-Ho Hong, Laurie H. Glimcher; IL-2 production in developing Th1 cells is regulated by heterodimerization of RelA and T-bet and requires T-bet serine residue 508 . J Exp Med 7 November 2005; 202 (9): 1289–1300. doi: https://doi.org/10.1084/jem.20051044
Download citation file:
Sign in
Don't already have an account? Register
Client Account
You could not be signed in. Please check your email address / username and password and try again.
Could not validate captcha. Please try again.
Sign in via your Institution
Sign in via your InstitutionSuggested Content
Email alerts
Advertisement